文献速递糖尿病

2型糖尿病患者相对白细胞端粒长度缩短与现患及新发心血管并发症相关:来自香港糖尿病登记处的分析

Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register.
PubMed 文献 · Diabetes Care · 2020-07-13

研究纳入香港糖尿病登记处5349例连续中国2型糖尿病患者,基线DNA可获取且随访数据完整,采用定量PCR测定相对白细胞端粒长度(rLTL),依据ICD-9编码诊断心血管疾病(CVD)。平均随访13.4年(SD 5.5年),基线合并CVD者rLTL较无CVD者缩短(4.3 ± 1.2 ΔΔCt vs 4.6 ± 1.2 ΔΔCt,P < 0.001);基线无CVD的4541例中,随访期间新发CVD的1140例rLTL较保持无CVD者缩短(4.3 ± 1.2 ΔΔCt vs 4.7 ± 1.2 ΔΔCt,P < 0.001)。校正年龄、性别、吸烟及白蛋白尿状态后,rLTL每降低1单位,新发CVD风险升高(HR 1.252,95%CI 1.195-1.311,P < 0.001);进一步校正年龄、性别、BMI、收缩压、LDL胆固醇、HbA1c、eGFR及ACR后仍显著(HR 1.141,95%CI 1.084-1.200,P < 0.001)。

要点

  • 基线合并CVD者rLTL较无CVD者缩短(4.3 ± 1.2 ΔΔCt vs 4.6 ± 1.2 ΔΔCt,P < 0.001)。
  • 基线无CVD者中新发CVD者rLTL较未发者缩短(4.3 ± 1.2 ΔΔCt vs 4.7 ± 1.2 ΔΔCt,P < 0.001)。
  • rLTL每降低1单位,新发CVD风险升高(校正后HR 1.141,95%CI 1.084-1.200,P < 0.001)。

核心结论

  • 2型糖尿病合并CVD患者rLTL显著缩短,rLTL与心脏代谢危险因素相关,且与新发CVD独立相关;端粒长度可能是2型糖尿病患者CVD风险的有用生物标志物。

研究设计与样本

  • 研究纳入香港糖尿病登记处连续中国2型糖尿病患者5349例,基线DNA可获取且随访数据完整,采用定量PCR测定rLTL,依据ICD-9编码诊断CVD。

主要发现

  • 平均随访13.4年(SD 5.5年),rLTL与年龄、糖尿病病程、血压、HbA1c及尿白蛋白与肌酐比值(ACR)呈负相关,与估算肾小球滤过率(eGFR)呈正相关(均P < 0.001)。
  • 基线合并CVD者rLTL较无CVD者缩短(4.3 ± 1.2 ΔΔCt vs 4.6 ± 1.2 ΔΔCt,P < 0.001)。
  • 基线无CVD的4541例中,随访期间新发CVD的1140例rLTL较保持无CVD者缩短(4.3 ± 1.2 ΔΔCt vs 4.7 ± 1.2 ΔΔCt,P < 0.001)。
  • Cox回归中,rLTL每降低1单位与新发CVD风险升高相关(HR 1.252,95%CI 1.195-1.311,P < 0.001)。
  • 校正年龄、性别、BMI、收缩压、LDL胆固醇、HbA1c、eGFR及ACR后,rLTL每降低1单位与新发CVD风险升高仍显著相关(HR 1.141,95%CI 1.084-1.200,P < 0.001)。

临床怎么用

  • 原文结论认为端粒长度可能是2型糖尿病患者CVD风险的有用生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several studies support potential links between relative leukocyte telomere length (rLTL), a biomarker of biological aging, and type 2 diabetes. This study investigates relationships between rLTL and incident cardiovascular disease (CVD) in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Consecutive Chinese patients with type 2 diabetes (N = 5,349) from the Hong Kong Diabetes Register for whom DNA obtained at baseline was stored and follow-up data were available were studied. rLTL was measured by using quantitative PCR. CVD was diagnosed on the basis of ICD-9 code. RESULTS: Mean follow-up was 13.4 years (SD 5.5 years). rLTL was correlated inversely with age, diabetes duration, blood pressure, HbA1c, and urine albumin-to-creatinine ratio (ACR), and positively with estimated glomerular filtration rate (eGFR) (all P < 0.001). Subjects with CVD at baseline had a shorter rLTL (4.3 ± 1.2 ΔΔCt) than did subjects without CVD (4.6 ± 1.2 ΔΔCt) (P < 0.001). Of the 4,541 CVD-free subjects at baseline, the 1,140 who developed CVD during follow-up had a shorter rLTL (4.3 ± 1.2 ΔΔCt) than those who remained CVD-free after adjusting for age, sex, smoking, and albuminuria status (4.7 ± 1.2 ΔΔCt) (P < 0.001). In Cox regression models, shorter rLTL was associated with higher risk of incident CVD (for each unit decrease, hazard ratio 1.252 [95% CI 1.195-1.311], P < 0.001), which remained significant after adjusting for age, sex, BMI, systolic blood pressure, LDL cholesterol, HbA1c, eGFR, and ACR (hazard ratio 1.141 [95% CI 1.084-1.200], P < 0.001). CONCLUSIONS: rLTL is significantly shorter in patients with type 2 diabetes and CVD, is associated with cardiometabolic risk factors, and is independently associated with incident CVD. Telomere length may be a useful biomarker for CVD risk in patients with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Cheng F, Luk AO, Tam CHT, et al. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 2020. PMID: 32661111. doi:10.2337/dc20-0028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。